Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
13.50
+0.15 (1.12%)
Dec 20, 2024, 4:00 PM EST - Market closed
Contineum Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$29.25
Upside
+116.67%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $32 → $31 | Buy | Maintains | $32 → $31 | +129.63% | Nov 7, 2024 |
| Baird | Baird | Buy Initiates $32 | Buy | Initiates | $32 | +137.04% | Oct 22, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $30 → $32 | Buy | Maintains | $30 → $32 | +137.04% | Aug 14, 2024 |
| Stifel | Stifel | Strong Buy Initiates $29 | Strong Buy | Initiates | $29 | +114.81% | Apr 30, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $30 | Buy | Initiates | $30 | +122.22% | Apr 30, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $25 | Buy | Initiates | $25 | +85.19% | Apr 30, 2024 |